Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarter Ended September 30, 2009
or
o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to
Commission File Number 000-09273
MOCON, INC.
(Exact name of registrant as specified in its charter)
Minnesota | | 41-0903312 |
(State or other jurisdiction of | | (I.R.S. employer |
incorporation or organization) | | identification no.) |
7500 Boone Avenue North, Minneapolis, Minnesota 55428
(Address of principal executive offices) (Zip code)
(763) 493-6370
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES o NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | | Accelerated filer o |
| | |
Non-accelerated filer o (do not check if a smaller reporting company) | | Smaller reporting company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO x
5,169,743 Common Shares were outstanding as of October 31, 2009.
Table of Contents
MOCON, INC. AND SUBSIDIARIES
INDEX TO FORM 10-Q
For the Quarter Ended September 30, 2009
| Page Number |
PART I. FINANCIAL INFORMATION | |
| |
Item 1. | Financial Statements | |
| | |
| Consolidated Balance Sheets (Unaudited) September 30, 2009 and December 31, 2008 | 1 |
| | |
| Consolidated Statements of Income (Unaudited) Three months and nine months ended September 30, 2009 and 2008 | 2 |
| | |
| Consolidated Statements of Cash Flows (Unaudited) Nine months ended September 30, 2009 and 2008 | 3 |
| | |
| Notes to Consolidated Financial Statements (Unaudited) | 4-9 |
| | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 9-19 |
| | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 19-20 |
| | |
Item 4T. | Controls and Procedures | 20 |
| | |
PART II. OTHER INFORMATION | |
| | |
Item 1A. | Risk Factors | 20 |
| | |
Item 2. | Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities | 21 |
| | |
Item 6. | Exhibits | 22 |
| |
Signatures | 23 |
| |
Exhibit Index | 24 |
| |
In this report, references to “MOCON,” “the Company,” “we,” “our,” or “us,” unless the context otherwise requires, refer to MOCON, Inc. and its subsidiaries. All trademarks or trade names referred to in this report are the property of their respective owners. |
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MOCON, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
| | September 30, | | December 31, | |
| | 2009 | | 2008 | |
| | | | | |
ASSETS | | | | | |
Current assets: | | | | | |
Cash and cash equivalents | | $ | 5,662,117 | | $ | 4,553,479 | |
Marketable securities, current | | 6,076,587 | | 7,087,373 | |
Trade accounts receivable, less allowance for doubtful accounts of $135,158 in 2009 and $137,182 in 2008 | | 4,158,868 | | 4,514,359 | |
Other receivables | | 136,639 | | 255,923 | |
Inventories | | 4,419,694 | | 4,731,859 | |
Prepaid income taxes | | 589,799 | | 465,641 | |
Prepaid expenses | | 410,930 | | 385,264 | |
Deferred income taxes | | 362,773 | | 362,773 | |
Total current assets | | 21,817,407 | | 22,356,671 | |
| | | | | |
Marketable securities, noncurrent | | 1,418,120 | | 4,468,064 | |
Property, plant and equipment, net of accumulated depreciation of $4,500,795 in 2009 and $4,274,454 in 2008 | | 1,728,425 | | 1,826,269 | |
| | | | | |
Other assets: | | | | | |
Goodwill | | 3,335,384 | | 3,267,926 | |
Technology rights and other intangibles, net | | 704,752 | | 659,298 | |
Deferred income taxes | | 298,094 | | 298,094 | |
Other | | 79,546 | | 76,905 | |
Total other assets | | 4,417,776 | | 4,302,223 | |
| | | | | |
TOTAL ASSETS | | $ | 29,381,728 | | $ | 32,953,227 | |
| | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
Current liabilities: | | | | | |
Accounts payable | | $ | 1,278,619 | | $ | 1,676,448 | |
Accrued compensation and vacation | | 1,130,945 | | 1,498,428 | |
Other accrued expenses | | 283,607 | | 310,828 | |
Accrued product warranties | | 211,108 | | 229,087 | |
Dividends payable | | 465,277 | | 503,308 | |
Deferred revenue | | 349,378 | | 245,793 | |
Total current liabilities | | 3,718,934 | | 4,463,892 | |
| | | | | |
Noncurrent liabilities: | | | | | |
Obligations to former employees | | 57,472 | | 55,522 | |
Accrued income taxes | | 194,873 | | 215,820 | |
Total noncurrent liabilities | | 252,345 | | 271,342 | |
| | | | | |
Total liabilities | | 3,971,279 | | 4,735,234 | |
| | | | | |
Stockholders’ equity: | | | | | |
Capital stock – undesignated. Authorized 3,000,000 shares | | — | | — | |
Common stock – $0.10 par value. Authorized 22,000,000 shares; issued and outstanding 5,169,743 shares in 2009 and 5,592,314 shares in 2008 | | 516,974 | | 559,231 | |
Additional paid-in capital | | 57,319 | | 2,868,669 | |
Retained earnings | | 24,033,283 | | 24,268,266 | |
Accumulated other comprehensive income | | 802,873 | | 521,827 | |
Total stockholders’ equity | | 25,410,449 | | 28,217,993 | |
| | | | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | | $ | 29,381,728 | | $ | 32,953,227 | |
See accompanying notes to consolidated financial statements.
1
Table of Contents
MOCON, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
| | Three Months Ended | | Nine Months Ended | |
| | September 30, | | September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Sales: | | | | | | | | | |
Products | | $ | 6,116,215 | | $ | 6,985,047 | | $ | 17,873,446 | | $ | 21,010,620 | |
Consulting services | | 484,344 | | 444,191 | | 1,320,208 | | 1,259,774 | |
Total sales | | 6,600,559 | | 7,429,238 | | 19,193,654 | | 22,270,394 | |
| | | | | | | | | |
Cost of sales: | | | | | | | | | |
Products | | 2,385,444 | | 2,602,113 | | 7,273,843 | | 8,256,538 | |
Consulting services | | 297,020 | | 264,426 | | 783,765 | | 742,886 | |
Total cost of sales | | 2,682,464 | | 2,866,539 | | 8,057,608 | | 8,999,424 | |
| | | | | | | | | |
Gross profit | | 3,918,095 | | 4,562,699 | | 11,136,046 | | 13,270,970 | |
| | | | | | | | | |
Selling, general and administrative expenses | | 2,267,755 | | 2,586,565 | | 7,340,218 | | 7,610,490 | |
| | | | | | | | | |
Research and development expenses | | 470,330 | | 433,630 | | 1,439,961 | | 1,460,594 | |
| | | | | | | | | |
Operating income | | 1,180,010 | | 1,542,504 | | 2,355,867 | | 4,199,886 | |
| | | | | | | | | |
Other income | | 91,729 | | 134,051 | | 320,308 | | 422,665 | |
| | | | | | | | | |
Income before income taxes | | 1,271,739 | | 1,676,555 | | 2,676,175 | | 4,622,551 | |
| | | | | | | | | |
Income taxes | | 398,000 | | 595,000 | | 888,000 | | 1,604,000 | |
| | | | | | | | | |
Net income | | $ | 873,739 | | $ | 1,081,555 | | $ | 1,788,175 | | $ | 3,018,551 | |
| | | | | | | | | |
Net income per common share: | | | | | | | | | |
Basic | | $ | 0.17 | | $ | 0.19 | | $ | 0.33 | | $ | 0.54 | |
Diluted | | $ | 0.16 | | $ | 0.19 | | $ | 0.32 | | $ | 0.53 | |
| | | | | | | | | |
Weighted average common shares outstanding: | | | | | | | | | |
Basic | | 5,250,543 | | 5,579,932 | | 5,467,507 | | 5,555,078 | |
Diluted | | 5,312,984 | | 5,700,069 | | 5,533,108 | | 5,672,630 | |
See accompanying notes to consolidated financial statements.
2
Table of Contents
MOCON, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| | Nine Months Ended | |
| | September 30, | |
| | 2009 | | 2008 | |
Cash flows from operating activities: | | | | | |
Net income | | $ | 1,788,175 | | $ | 3,018,551 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Stock-based compensation expense | | 173,050 | | 227,929 | |
Loss on disposition of long-term assets | | 8,053 | | 31,776 | |
Depreciation and amortization | | 440,284 | | 433,482 | |
Deferred income taxes | | — | | (56,708 | ) |
Excess tax benefit from employee stock plans | | (25 | ) | (24,570 | ) |
Changes in operating assets and liabilities: | | | | | |
Trade accounts receivable | | 78,020 | | (191,663 | ) |
Other receivables | | 118,892 | | (33,377 | ) |
Inventories | | 344,180 | | (629,838 | ) |
Prepaid income taxes | | (98,825 | ) | — | |
Prepaid expenses | | (25,050 | ) | (505,210 | ) |
Accounts payable | | (118,054 | ) | 503,968 | |
Accrued compensation and vacation | | (375,317 | ) | (69,365 | ) |
Other accrued expenses | | (25,331 | ) | (33,901 | ) |
Accrued product warranties | | (20,008 | ) | 25,216 | |
Accrued income taxes | | (25,560 | ) | (55,846 | ) |
Deferred revenue | | 103,585 | | (68,545 | ) |
Net cash provided by operating activities | | 2,366,069 | | 2,571,899 | |
| | | | | |
Cash flows from investing activities: | | | | | |
Purchases of marketable securities | | (979,101 | ) | (7,658,216 | ) |
Proceeds from maturities of marketable securities | | 5,037,304 | | 5,450,686 | |
Purchases of property, plant and equipment | | (258,816 | ) | (348,626 | ) |
Proceeds from sale of property and equipment | | 3,066 | | 7,817 | |
Purchases of patents and trademarks | | (106,785 | ) | (112,775 | ) |
Other | | (2,641 | ) | (2,582 | ) |
Net cash provided by (used in) investing activities | | 3,693,027 | | (2,663,696 | ) |
| | | | | |
Cash flows from financing activities: | | | | | |
Proceeds from the exercise of stock options | | 7,685 | | 491,062 | |
Purchases and retirement of common stock | | (3,602,083 | ) | (1,968 | ) |
Excess tax benefit from employee stock plans | | 25 | | 24,570 | |
Dividends paid | | (1,493,473 | ) | (1,359,833 | ) |
Net cash used in financing activities | | (5,087,846 | ) | (846,169 | ) |
| | | | | |
Effect of exchange rate changes on cash and cash equivalents | | 137,388 | | (75,108 | ) |
| | | | | |
Net increase (decrease) in cash and cash equivalents | | 1,108,638 | | (1,013,074 | ) |
| | | | | |
Cash and cash equivalents: | | | | | |
Beginning of period | | 4,553,479 | | 5,207,105 | |
End of period | | $ | 5,662,117 | | $ | 4,194,031 | |
| | | | | |
Supplemental disclosures of cash flow information: | | | | | |
Cash paid during the period for income taxes | | $ | 971,979 | | $ | 1,752,228 | |
| | | | | |
Supplemental schedule of noncash investing and financing activities: | | | | | |
Amortization of cumulative unrealized gain on marketable securities | | $ | (2,527 | ) | $ | (18,937 | ) |
Dividends accrued | | $ | 465,277 | | $ | 475,873 | |
See accompanying notes to consolidated financial statements.
3
Table of Contents
MOCON, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 — Consolidated Financial Statements
The consolidated balance sheet as of September 30, 2009, and the consolidated statements of income and cash flows for the three- and nine-month periods ended September 30, 2009 and 2008 have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim unaudited consolidated financial statements reflect all adjustments which are, in the opinion of management, necessary to fairly present the financial position, results of operations and cash flows at September 30, 2009, and for all periods presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.
The results of operations for the three- and nine-month periods ended September 30, 2009 are not necessarily indicative of operating results for the full year. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, previously filed with the Securities and Exchange Commission.
We operate in a single industry segment: the developing, manufacturing, and marketing of measurement, analytical, monitoring and consulting products for customers in the barrier packaging, food, pharmaceutical, consumer products, industrial hygiene, air quality monitoring, oil and gas exploration and other industries throughout the world.
Principles of Consolidation
The consolidated financial statements include the accounts of MOCON, Inc. and its subsidiaries after elimination of inter-company transactions and accounts.
Foreign Currency Translation
The financial statements for operations outside the United States are maintained in their local currency. All assets and liabilities of our foreign subsidiaries are translated to United States dollars at period-end exchange rates, while revenue and expense accounts are translated at the average exchange rates during the period transactions occurred. Translation adjustments arising from the use of differing exchange rates are included in accumulated other comprehensive income or loss in stockholders’ equity. Gains and losses on foreign currency transactions are included in other income or loss.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management adjusts such estimates and assumptions when facts and circumstances change. Illiquid credit markets, volatile equity, foreign currency and energy markets, and declines in business and consumer spending have combined to increase the uncertainty inherent in such estimates and assumptions. Actual results could differ from those estimates.
4
Table of Contents
Subsequent Events
We have evaluated subsequent events through November 13, 2009, the date these consolidated financial statements were issued.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and short-term debt approximates fair value due to the short maturity of those instruments.
Recently Issued Accounting Pronouncements
In June 2009, the Financial Accounting Standards Board (FASB) issued Update No. 2009-01, which establishes The FASB Accounting Standards Codification (ASC) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (GAAP). The ASC is effective for interim and annual periods ending after September 15, 2009. We have adopted the ASC when referring to GAAP in this report on Form 10-Q for the quarter ended September 30, 2009. The adoption of the ASC did not have an impact on our consolidated financial statements.
In September 2006, the FASB issued guidance, now codified as ASC Topic 820, Fair Value Measurements and Disclosures, which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. In February 2008, the FASB released additional guidance, also now codified under ASC Topic 820, which provided for delayed application of certain guidance related to non-financial assets and non-financial liabilities not measured at fair value on a recurring basis. We adopted ASC Topic 820 in the first quarter 2008, except as it applies to those non-financial assets and non-financial liabilities, which was adopted in the first quarter 2009. Although we believe the adoption of this guidance may impact the way that we determine the fair value of goodwill, indefinite-lived intangible assets, and other long-lived assets, we do not expect it to have a material impact on our results of operations or financial condition.
Note 2 — Inventories
Inventories consist of the following:
| | September 30, 2009 | | December 31, 2008 | |
Finished products | | $ | 904,486 | | $ | 829,861 | |
Work-in-process | | 1,436,464 | | 1,633,577 | |
Raw materials | | 2,078,744 | | 2,268,421 | |
| | $ | 4,419,694 | | $ | 4,731,859 | |
Note 3 — Net Income Per Common Share
Basic net income per common share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per common share is computed using the treasury stock method to compute the weighted average common stock outstanding assuming the conversion of potential dilutive common shares.
The following table presents a reconciliation of the denominators used in the computation of net income per common share — basic, and net income per common share — diluted, for the three- and nine-month periods ended September 30, 2009 and 2008:
5
Table of Contents
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Weighted shares of common stock outstanding – basic | | 5,250,543 | | 5,579,932 | | 5,467,507 | | 5,555,078 | |
Weighted shares of common stock assumed upon exercise of stock options | | 62,441 | | 120,137 | | 65,601 | | 117,552 | |
Weighted shares of common stock outstanding – diluted | | 5,312,984 | | 5,700,069 | | 5,533,108 | | 5,672,630 | |
For the three- and nine-month periods ended September 30, 2009, there were 481,024 stock options outstanding that were excluded from the above computation because they were anti-dilutive.
Note 4 — Goodwill and Intangible Assets
As of September 30, 2009 and December 31, 2008, goodwill amounted to $3,335,384 and $3,267,926, respectively. The increase was due to foreign currency translation relating to the acquisition of Paul Lippke Handels-GmbH. Other identifiable intangible assets (all of which are being amortized except projects in process) are as follows:
| | As of September 30, 2009 | |
| | Cost | | Accumulated Amortization | | Net | | Estimated Useful Lives | |
Patents | | $ | 958,207 | | $ | (390,804 | ) | $ | 567,403 | | 10 to 17 years | |
Trademarks and trade names | | 470,846 | | (393,497 | ) | 77,349 | | 5 to 17 years | |
Other intangibles | | 778,596 | | (718,596 | ) | 60,000 | | 3 years | |
| | $ | 2,207,649 | | $ | (1,502,897 | ) | $ | 704,752 | | | |
| | As of December 31, 2008 | |
| | Cost | | Accumulated Amortization | | Net | | Estimated Useful Lives | |
Patents | | $ | 860,422 | | $ | (365,329 | ) | $ | 495,093 | | 10 to 17 years | |
Trademarks and trade names | | 465,756 | | (381,551 | ) | 84,205 | | 5 to 17 years | |
Other intangibles | | 778,596 | | (698,596 | ) | 80,000 | | 3 years | |
| | $ | 2,104,774 | | $ | (1,445,476 | ) | $ | 659,298 | | | |
Total amortization expense for the three-month periods ended September 30, 2009 and 2008 was $21,588 and $29,293, respectively, and $63,285 and $85,755 for the nine-month periods ended September 30, 2009 and 2008. Projects in process are not amortized until the patent or trademark is granted by the regulatory agency. Estimated amortization expense for the remainder of 2009 and each of the four succeeding fiscal years and thereafter based on the intangible assets as of September 30, 2009 is as follows:
| | Estimated Expense | |
2009 | | $ | 22,147 | |
2010 | | $ | 79,867 | |
2011 | | $ | 66,228 | |
2012 | | $ | 33,803 | |
2013 | | $ | 29,110 | |
2014 and thereafter | | $ | 144,847 | |
6
Table of Contents
Note 5 — Marketable Securities
As of January 1, 2008, the classification of our marketable debt securities was changed from available-for-sale to held-to-maturity. This change was made due to our current intent and ability to hold these securities until maturity or the call date as the case may be. Currently, all of our marketable securities mature within two years. Held-to-maturity securities are recorded at amortized cost, adjusted for the amortization or accretion of premiums or discounts. A decline in the market value of any held-to-maturity security below the amortized cost basis that is deemed other than temporary is charged to income, resulting in the establishment of a new cost basis for the security. There was no impairment during the first nine months of 2009, therefore no adjustment to the amortized cost basis was made. Under the prior method, these securities were recorded at fair value and the unrealized holding gains and losses were excluded from income and reported as a separate component of stockholders’ equity until realized. For the debt securities that were outstanding at December 31, 2007, there was approximately $25,000 of unrealized gain that was recorded in stockholders’ equity, which was amortized over the remaining life of the securities. This unrealized gain was fully amortized as of March 31, 2009.
The amortized cost and fair value for held-to-maturity securities by major security type at September 30, 2009 were as follows:
| | September 30, 2009 | |
| | Amortized Cost | | Fair Value | |
Certificates of deposit | | $ | 4,100,959 | | $ | 4,101,000 | |
Municipal bonds | | 3,393,748 | | 3,422,629 | |
| | $ | 7,494,707 | | $ | 7,523,629 | |
Note 6 — Comprehensive Income
Other comprehensive income pertains to foreign currency translation adjustments that are not included in net income but rather are recorded directly in stockholders’ equity.
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Net income | | $ | 873,739 | | $ | 1,081,555 | | $ | 1,788,175 | | $ | 3,018,551 | |
Foreign currency translation adjustment | | 293,571 | | (450,679 | ) | 283,573 | | (120,324 | ) |
Amortization of cumulative unrealized gain on marketable securities | | — | | (4,475 | ) | (2,527 | ) | (18,937 | ) |
Comprehensive income | | $ | 1,167,310 | | $ | 626,401 | | $ | 2,069,221 | | $ | 2,879,290 | |
Note 7 — Note Payable - Bank
During the second quarter 2009, we executed a $1,000,000 revolving line of credit agreement with a bank to supplement our working capital requirements. The full amount of the line was borrowed during the second quarter 2009 and repaid in the third quarter, together with interest calculated at 2.25% above the daily three month LIBOR rate. There were no restrictive covenants or compensating balance requirements associated with this line of credit. As of September 30, 2009, there were no amounts outstanding under this line of credit.
7
Table of Contents
Note 8 — Warranty
We provide a warranty for most of our products. Warranties are for periods ranging from ninety days to one year, and cover parts and labor for non-maintenance repairs, at our location. Operator abuse, improper use, alteration, damage resulting from accident, or failure to follow manufacturer’s directions are excluded from warranty coverage.
Warranty expense is accrued at the time of sale based on historical claims experience. Warranty reserves are also accrued for special rework campaigns for known major product modifications. We also offer extended warranty service contracts for select products when the factory warranty period expires.
Warranty provisions and claims for the nine-month periods ended September 30, 2009 and 2008 were as follows:
| | Nine Months Ended September 30, | |
| | 2009 | | 2008 | |
Beginning balance | | $ | 229,087 | | $ | 201,373 | |
Warranty provisions | | 187,349 | | 284,346 | |
Warranty claims | | (205,328 | ) | (259,830 | ) |
Ending balance | | $ | 211,108 | | $ | 225,889 | |
Note 9 — Income Taxes
MOCON, Inc. or one of our subsidiaries files income tax returns in the U.S. federal jurisdiction, several state jurisdictions, China and Germany. With limited exceptions, we are no longer subject to income tax examinations by taxing authorities for taxable years before 2006.
As of December 31, 2008, the liability for gross unrecognized tax benefits was $168,000, which included potential benefits of $121,000 that, if recognized, would affect the effective tax rate. During the nine months ended September 30, 2009, there were no significant changes to the total gross unrecognized tax benefits that would have a material effect on results of operations. In the third quarter 2009, the provision for unrecognized tax benefits was reduced slightly to reflect the closing of the statute of limitations on a certain tax year. It is expected that the amount of unrecognized tax benefits for positions which we have identified will not change significantly in the next twelve months.
Note 10 — Stock-Based Compensation
As of September 30, 2009, we have reserved 234,675 shares of common stock for options and other stock-based incentive awards that are still available for grant under our 2006 stock incentive plan, and 844,012 shares for options that have been granted under either the 2006 stock incentive plan or the 1998 stock option plan but have not yet been exercised. We issue new shares of common stock upon exercise of stock options. There were no options granted in the first nine months of 2009.
Amounts recognized in the consolidated financial statements related to stock-based compensation are as follows:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Total cost of stock-based compensation | | $ | 57,319 | | $ | 73,862 | | $ | 173,050 | | $ | 227,929 | |
Amount of income tax benefit recognized in earnings | | (2,657 | ) | (8,256 | ) | (8,306 | ) | (38,435 | ) |
Amount charged against net income | | $ | 54,662 | | $ | 65,606 | | $ | 164,744 | | $ | 189,494 | |
8
Table of Contents
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model (Black-Scholes). We use historical data to estimate the expected price volatility, expected option life and expected forfeiture rate. We base our estimate of expected volatility for awards granted on daily historical trading data of our common stock for a period equivalent to the expected term of the award. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. We estimate the expected term consistent with historical exercise and cancellation activity of our previous share-based grants with a ten-year contractual term. Forfeitures are based on historical experience. The dividend yield is calculated based upon the dividend payments made during the prior four quarters as a percent of the average stock price for that period.
A summary of the option activity for the first nine months of 2009 is as follows:
| | Number of Shares | | Weighted Average Exercise Price per Share | | Weighted Average Remaining Contractual Term | | Aggregate Intrinsic Value | |
Outstanding at December 31, 2008 | | 848,562 | | $ | 8.81 | | 4.9 | | $ | 567,879 | |
Options granted | | — | | — | | — | | | |
Options cancelled/expired | | (3,550 | ) | $ | 10.31 | | — | | | |
Options exercised | | (1,000 | ) | $ | 7.69 | | — | | | |
Outstanding at September 30, 2009 | | 844,012 | | $ | 8.81 | | 4.1 | | $ | 556,099 | |
| | | | | | | | | |
Exercisable at September 30, 2009 | | 708,043 | | $ | 8.60 | | 3.8 | | $ | 556,099 | |
The total intrinsic value of options exercised was $0 and $154,901 during the three-month periods ended September 30, 2009 and 2008, respectively, and $985 and $296,689 during the first nine months of 2009 and 2008, respectively.
A summary of the status of our unvested option shares as of September 30, 2009 is as follows:
| | Number of Shares | | Weighted Average Grant Date Fair Value | |
Unvested at December 31, 2008 | | 163,469 | | $ | 2.47 | |
Options granted | | — | | — | |
Options cancelled | | (2,375 | ) | $ | 2.59 | |
Options vested | | (25,125 | ) | $ | 2.40 | |
Unvested at September 30, 2009 | | 135,969 | | $ | 2.48 | |
As of September 30, 2009, there was $225,030 of total unrecognized compensation cost related to unvested stock-based compensation granted under our plans. That cost is expected to be recognized over a weighted-average period of 1.4 years. The total fair value of option shares vested during the three-month periods ended September 30, 2009 and 2008 was $20,100 and $26,883, respectively, and $60,300 and $80,651 during the nine-month periods ended September 30, 2009 and 2008, respectively.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Management’s Discussion and Analysis provides material historical and prospective disclosures intended to enable investors and other users to assess our financial condition and results of operations. Statements that are not historical are forward-looking and involve risks and uncertainties discussed
9
Table of Contents
below under the caption “Forward-Looking Statements.” The following discussion of the results of operations and financial condition of MOCON should be read in conjunction with our consolidated financial statements and the related notes thereto included elsewhere in this report.
Overview
Description of Business
MOCON, Inc. designs, manufactures, markets and services products, and provides consulting services, primarily in the measurement and analytical instrument and services markets. Our products include instruments that measure gases and chemical compounds in a variety of applications. We continually seek growth opportunities through technological and product improvement, by acquiring and developing new products, and by acquiring companies we consider to be strategically important.
We have three primary operating locations in the United States — Minnesota, Colorado and Texas — and foreign facilities in Germany and China. We use a combination of a direct sales force and independent sales representatives to market our products and services in the United States, Canada, Germany and China, and use a network of independent sales representatives to market and service our products and services in other foreign countries. In recent years, over half of our revenues have come from international customers.
Our current plans for growth include continued strong funding for research and development (approximately 6% to 8% of our revenue) to foster new product development, together with strategic acquisitions where appropriate. Our products are used by customers in many different markets. A significant focus of our product development and marketing efforts in 2009 has been in the food and beverage markets. Our target customers in this market are primarily interested in three things: developing successful new consumer products, maintaining high quality in their products and ensuring the shelf life and safety of their products. Food safety has been in the news a great deal lately, and our newest products help address the increased consumer emphasis on health and safety.
Market Strategy
Our BevAlert® system tests the purity of carbon dioxide used to carbonate soft drinks, beer and mineral waters around the world. As manufacturers of these consumer beverages expand their businesses and operations, especially into underdeveloped countries, they are increasingly investing in better instrumentation to ensure the final product is free of potential contaminants. We feel our BevAlert system is well suited to addressing the concerns of manufacturers of beverages, and we estimate that the addressable market for purity testing systems in the beverage industry could be as much as an aggregate of $105 million over the next ten years. We believe this could be a growth opportunity for us as our sales of the BevAlert system have been ramping up in the past two years.
We have recently developed and introduced our OpTech-O2™ Platinum oxygen analyzer, which is able to measure the oxygen concentration in a food, beverage, pharmaceutical or medical device package without piercing the package. This new technology, which went into production in the third quarter of 2009, will enable manufacturers in these industries to track and trace their products during manufacture and distribution, and follow changes in oxygen levels as they occur. Applications include looking for poor heat seals or leaks, excessive package permeation, poor gas flushing and microbial growth. All of these issues affect product acceptance, product quality and product safety. We believe the addressable market for products in these industries that have the functionality of our OpTech-O2 Platinum oxygen analyzer could be as high as an aggregate of $75 million over the next ten years.
In the cases of both the BevAlert and the OpTech products, MOCON is targeting the worldwide increase in concern for consumer safety in the food and beverage markets. Our strategy is to continue to position ourselves as a leader in the consumer and industrial safety marketplace by offering unique products and services into large and growing markets.
Results of Operations
The following table sets forth the relationship between various components of our results of operations,
10
Table of Contents
stated as a percent of sales, for the three- and nine-month periods ended September 30, 2009 and 2008:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Sales | | 100.0 | | 100.0 | | 100.0 | | 100.0 | |
Cost of sales | | 40.6 | | 38.6 | | 42.0 | | 40.4 | |
Gross profit | | 59.4 | | 61.4 | | 58.0 | | 59.6 | |
Selling, general and administrative expenses | | 34.4 | | 34.8 | | 38.2 | | 34.2 | |
Research and development expenses | | 7.1 | | 5.8 | | 7.5 | | 6.5 | |
Operating income | | 17.9 | | 20.8 | | 12.3 | | 18.9 | |
Other income | | 1.3 | | 1.8 | | 1.6 | | 1.9 | |
Income before income taxes | | 19.2 | | 22.6 | | 13.9 | | 20.8 | |
Income taxes | | 6.0 | | 8.0 | | 4.6 | | 7.2 | |
Net income | | 13.2 | | 14.6 | | 9.3 | | 13.6 | |
Comparison of Financial Results for the Three- and Nine-Month Periods Ended September 30, 2009 and 2008
Sales
Sales for the three-month period ended September 30, 2009 were $6,601,000, down 11% compared to $7,429,000 for the same period in 2008. Although total sales in the current quarter were higher than the first and second quarters of 2009, the global economic slowdown continued to affect sales across most major product lines and foreign market regions. On a geographical basis, sales decreased 25% in our foreign markets, offset somewhat by an increase of 11% in our domestic markets. This increase in our domestic market was primarily due to a lower than normal quarter in the prior year. Domestic and foreign sales accounted for 47% and 53%, respectively, of our consolidated third quarter sales in 2009, and 38% and 62% of our consolidated sales, respectively, for the same period in 2008.
Sales for the nine-month period ended September 30, 2009 were $19,194,000, down 14% compared to $22,270,000 for the same period in 2008. Sales in the prior period benefited from a weaker U.S. dollar which made our products and services more attractive in the European market. On a geographical basis, sales decreased 10% and 17% in our domestic and foreign markets, respectively. Domestic and foreign sales accounted for 46% and 54%, respectively, of our consolidated sales for the first nine months of 2009, and 44% and 56% for the same period in 2008.
The following table summarizes total sales by product line for the three- and nine-month periods ended September 30, 2009 and 2008:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Permeation products and services | | $ | 3,686,452 | | $ | 3,814,399 | | $ | 10,898,104 | | $ | 12,050,577 | |
Gas, headspace, and other analyzer products and services | | 2,546,196 | | 3,395,414 | | 7,293,244 | | 9,175,977 | |
Other instruments and services | | 367,911 | | 219,425 | | 1,002,306 | | 1,043,840 | |
| | $ | 6,600,559 | | $ | 7,429,238 | | $ | 19,193,654 | | $ | 22,270,394 | |
11
Table of Contents
The following table sets forth the relationship between various components of domestic and foreign sales for the three- and nine-month periods ended September 30, 2009 and 2008:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Domestic sales | | $ | 3,134,175 | | $ | 2,812,010 | | $ | 8,797,511 | | $ | 9,760,948 | |
Foreign sales: | | | | | | | | | |
Europe | | 1,588,609 | | 1,992,022 | | 4,951,756 | | 5,765,695 | |
Asia | | 1,531,533 | | 1,781,861 | | 4,074,714 | | 4,706,561 | |
Other | | 346,242 | | 843,345 | | 1,369,673 | | 2,037,190 | |
Total foreign sales | | 3,466,384 | | 4,617,228 | | 10,396,143 | | 12,509,446 | |
| | $ | 6,600,559 | | $ | 7,429,238 | | $ | 19,193,654 | | $ | 22,270,394 | |
Permeation Products and Services — Sales of our permeation products and services, which accounted for 56% and 51% of our consolidated third quarter sales in 2009 and 2008, respectively, decreased 3% during the third quarter 2009 compared to the same period in 2008. The decrease was a result of lower shipments to our international markets, partially offset by an increase in shipments in our domestic markets. International sales of permeation products and services accounted for 68% of the total sales of this product group in the third quarter 2009, and 75% of the total sales in this product group for the third quarter 2008.
Sales of our permeation products and services, which accounted for approximately 57% and 54% of our consolidated sales during the first nine months in 2009 and 2008, respectively, decreased 10% during the first nine months of 2009 compared to the same period in 2008. The decrease was primarily the result of lower international shipments, as domestic sales were relatively constant between the periods. International sales of permeation products and services accounted for 66% of the total sales of this product group in the first nine months of 2009, and 69% of the total sales in this product group for the third quarter 2008.
Gas, Headspace, and Other Analyzer Products and Services — Sales of our gas, headspace, and other analyzer products and services, which accounted for 39% and 46% of our consolidated third quarter sales in 2009 and 2008, decreased 25% during the third quarter 2009 compared to the same period in 2008. Within this group, sales of our gas analyzer products through our Baseline subsidiary decreased 23% due primarily to lower demand for gas chromatograph and total hydrocarbon analyzer instruments to the oil and gas drilling and environmental markets. In addition, the prior year benefitted from a large order for gas chromatographs for an environmental application. The decrease in sales of instruments was partially offset by an increase in sales of gas sensors and detectors. Also in this group, sales of our packaging products decreased 21% during the third quarter 2009 compared to the same period in 2008 primarily due to lower demand for our headspace analyzer and leak detection equipment, primarily in our foreign markets.
Sales of our gas, headspace, and other analyzer products and services, which accounted for 38% and 41% of our consolidated sales during the first nine months in 2009 and 2008, respectively, decreased 21% during the first nine months of 2009 compared to the same period in 2008. Sales of our gas analyzer products decreased 25% due to lower demand for capital equipment instruments. This decrease was partially offset by an increase in sales of gas sensors and detectors. Sales of our packaging products decreased 6% during the first nine months of 2009 compared to the same period in 2008 primarily due to lower demand for our headspace analyzer and leak detection equipment, primarily in our foreign markets.
Other Instruments and Services — Sales in our other instruments and services category, which accounted for 5% and 3% of our consolidated third quarter sales in 2009 and 2008, respectively,
12
Table of Contents
increased 68% in the third quarter 2009, compared to the same period in 2008. This increase was due primarily to an increase in contract manufacturing of sample preparation products and increased sales of non-MOCON products by our German subsidiary.
Sales in our other instruments and services category, which accounted for 5% of our consolidated sales during the first nine months in both 2009 and 2008, decreased 4% during the first nine months of 2009, compared to the same period in 2008. This decrease was due primarily to a reduction in contract manufacturing of sample preparation products.
Gross Profit
The gross profit margins for our product sales were 61.0% and 62.7% for the three-month periods ended September 30, 2009 and 2008, respectively. Although the margin is lower in the current period, it is better than the first two quarters of 2009 and above historical trends. This improvement was partially the result of changes in the manufacturing process for sensors and detectors to increase efficiency and reduce rework. The prior year margin was strong due to a price increase on gas chromatographs and higher plant utilization. The gross profit margins for our consulting services were 38.7% and 40.5%, respectively, for the three-month periods ended September 30, 2009 and 2008. This decrease was primarily due to the varying margins between consulting service projects.
For the nine months ended September 30, 2009 and 2008, the gross profit margins for our products were 59.3% and 60.7%, respectively. This decrease was primarily due to lower shipment of permeation equipment which typically carries a higher margin, as well as lower volume over which to allocate fixed manufacturing costs. For the nine months ended September 30, 2009 and 2008, the gross profit margins for our consulting services were consistent at 40.6% and 41.0%, respectively.
Selling, General and Administrative Expenses
Selling, general and administrative (SG&A) expenses were $2,268,000 in the three-month period ended September 30, 2009, compared to $2,587,000 in the same period of 2008. As a percentage, SG&A expenses were consistent at 34.4% and 34.8% of consolidated sales in the third quarters of 2009 and 2008, respectively. Higher wages and benefits were offset by lower incentive compensation, travel, marketing and stock option expenses in the third quarter 2009 compared to the same period in 2008.
SG&A expenses were $7,340,000 in the nine-month period ended September 30, 2009, compared to $7,610,000 in the same period of 2008. As a percentage, SG&A expenses were 38.2% and 34.2% of consolidated sales in the first nine months of 2009 and 2008, respectively. This percentage increase was due to the lower sales level in 2009. Higher wages and benefits and increased marketing and trade show expenses were offset by lower incentive compensation, stock option expense, travel and professional fees in the first nine months of 2009 compared to the same period in the prior year.
Research and Development Expenses
Research and development (R&D) expenses were $470,000, or 7.1% of sales in the third quarter 2009, compared to $434,000, or 5.8% of sales, in the same period of 2008. R&D expenses were $1,440,000, or 7.5% of sales in the first nine months of 2009, compared to $1,461,000, or 6.5% of sales, in the same period of 2008. A significant portion of the resources expended in the third quarter 2009 and the year-to-date were related to the development of the OpTech-O2 Platinum oxygen analyzer.
Our intent is to continue to spend between 6% and 8% of consolidated sales on R&D.
Other Income
Other income for the three- and nine-month periods ended September 30, 2009 and 2008 was as
13
Table of Contents
follows:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
Interest income | | $ | 92,251 | | $ | 149,408 | | $ | 313,167 | | $ | 429,686 | |
Foreign currency exchange (loss) gain | | (102 | ) | (15,357 | ) | 4,491 | | (9,564 | ) |
Other | | (420 | ) | — | | 2,650 | | 2,543 | |
| | $ | 91,729 | | $ | 134,051 | | $ | 320,308 | | $ | 422,665 | |
Interest income decreased for both the third quarter and nine months ended September 30, 2009, compared to the same periods in 2008, due to lower average yields on lower average interest bearing investments.
Income Tax Expense
Our provision for income taxes was 31.3% of income before income taxes for the third quarter ended September 30, 2009, compared to 35.5% of income before income taxes for the third quarter ended September 30, 2008. This decrease in the effective tax rate in the third quarter 2009 was primarily due to the impact of discrete items arising from the completion of the 2008 income tax returns as well as a reduction in the reserve for uncertain tax positions as a result of the expiration of the statute of limitations in certain jurisdictions.
For the nine months ended September 30, 2009, our provision for income taxes was 33.2% of income before income taxes compared to 34.7% of income before income taxes for the similar period in the prior year. The lower rate in the current year was primarily due to the effects of discrete items recorded in the third quarter 2009.
Based on current projected annual operating results and current income tax rates, we expect the effective tax rate for the remainder of 2009 to be in the range of 33% to 36%. This rate fluctuates over time based on the income tax rates in the various jurisdictions in which we operate, and also the level of profits in those jurisdictions.
Net Income
Net income was $874,000 in the third quarter 2009, compared to $1,082,000 in the third quarter 2008. Diluted net income per share was $0.16 and $0.19 in the third quarters of 2009 and 2008, respectively. For the nine months ended September 30, 2009, net income was $1,788,000, or $0.32 per diluted share, compared to net income of $3,019,000, or $0.53 per diluted share in the prior year.
Liquidity and Capital Resources
We have historically financed our operations, capital expenditures and other liquidity needs through our cash flows generated from operations. We have a commitment for a $5 million revolving line of credit to supplement current working capital requirements. This line would replace the prior commitment of $1 million and would be used to supplement our available cash on hand in the event we see a strategic use. Total cash, cash equivalents and marketable securities decreased $2,952,000 during the first nine months of 2009 to $13,157,000 as of September 30, 2009, compared to $16,109,000 at December 31, 2008. The primary reason for this decrease was due to the repurchase during the first three quarters of 2009 of an aggregate of 423,571 shares of our common stock for a total of $3,602,000. Our working capital as of September 30, 2009 increased $206,000 to $18,098,000, as compared to $17,893,000 at December 31, 2008. We invest our excess cash in marketable securities consisting primarily of
14
Table of Contents
municipal bonds, certificates of deposits and U.S. treasury obligations. We believe that a combination of our existing cash, cash equivalents and marketable securities, revolving credit line and cash flow from operations will continue to be adequate to fund our operations, capital expenditures, dividend payments and authorized stock repurchases for at least the next twelve months. Purchases of property and equipment decreased $90,000 to $259,000 in the first nine months of 2009 as compared to the same period in 2008, and we had no material commitments for capital expenditures as of September 30, 2009.
One of our strategic objectives is, as market and business conditions warrant, to consider acquisitions of businesses, products or technologies. We may need to fund such activities, should they arise, with a combination of cash on hand and debt and/or equity financing, although no assurance can be given that such debt and/or equity financing will be available at reasonable terms or at all. In addition, there can be no assurance that we would be able to continue to pay dividends or pay dividends at current levels. If we raise additional funds by issuing debt, we may be subject to restrictive covenants that could limit our operational flexibility and higher interest expense could dilute earnings per share. Any plan to raise additional capital may involve an equity-based or equity-linked financing, which may be dilutive to existing shareholders.
Cash Flow
Cash Flow from Operating Activities
Our primary source of funds is cash provided by operating activities which totaled $2,366,000 and $2,572,000 in the first nine months of 2009 and 2008, respectively. The key components of the cash provided by operating activities in 2009 were the income for the period, reduced inventories and other receivables, and increased deferred revenue. These were partially offset by a reduction of accounts payable and a reduction in accrued compensation and vacation, which was primarily due to the March and July 2009 payments of incentive bonuses. The March payment related to compensation that was based on 2008 results.
Cash Flow from Investing Activities
Cash provided by (used in) investing activities totaled $3,693,000 and ($2,664,000) in the first nine months of 2009 and 2008, respectively. The primary reasons for cash provided by investing activities in 2009 were net proceeds from maturities of marketable securities of $4,058,000, offset somewhat by purchases of property and equipment, and patents and trademarks. We presently do not believe that any significant property, plant and equipment expenditures are required to accommodate our current level of operations.
Cash Flow from Financing Activities
Cash used in financing activities totaled $5,088,000 and $846,000 in the first nine months of 2009 and 2008, respectively. During the first nine months of 2009 we repurchased an aggregate of $3,602,000 of our common stock, $2,012,000 of which was in the third quarter. In addition, we made dividend payments to our shareholders of $1,493,000.
In June 2009, our Board of Directors authorized, depending upon market conditions and other factors, the repurchase of up to a total of $2 million of our common stock. During the third quarter 2009, we used the entire amount of the authorization by purchasing 242,400 shares of our common stock at an average price of $8.25 per share. Currently, the Board has not authorized any additional amounts to be used for stock repurchases.
Contractual Obligations
We refer you to our Annual Report on Form 10-K for the year ended December 31, 2008 for a summary
15
Table of Contents
of our contractual obligations. There has been no material change in this information.
Off-Balance Sheet Arrangements
Except for operating leases entered into in the ordinary course of business and customary indemnification obligations under certain of our agreements entered into in the ordinary course of business, we do not have any material off-balance sheet arrangements.
Recently Issued Accounting Pronouncements
In June 2009, new guidance was issued by the FASB, now codified in ASC Topic 810, which amends the consolidation guidance applicable to variable interest entities and is effective for us beginning July 1, 2010. We believe the adoption of this pronouncement will not have a significant impact on our consolidated financial statements.
In September 2009, the FASB ratified its guidance on two revenue recognition standards that will become effective for us beginning January 1, 2011, with earlier adoption permitted. Under the new guidance on revenue arrangements with multiple deliverables, when vendor specific objective evidence or third party evidence for deliverables in an arrangement cannot be determined, a best estimate of the selling price is required to separate deliverables and allocate arrangement consideration using the relative selling price method. Under the new guidance on arrangements that include software elements, tangible products that have software components that are essential to the functionality of the tangible product will no longer be within the scope of the software revenue recognition guidance, and software-enabled products will now be subject to the new guidance for multiple deliverable arrangements discussed above. In the initial year of application, companies are required to make qualitative and quantitative disclosures about the impact of the changes under both standards. We are currently evaluating the impact of adopting the new revenue recognition guidance on our consolidated financial statements and related disclosures.
Critical Accounting Policies
Our significant accounting policies are described in Note 1 to our consolidated financial statements. This Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires management to make estimates and judgments that affect the reported amount of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Securities and Exchange Commission has defined a company’s most critical accounting policies as those that are most important to the portrayal of its financial condition and results of operations, and which require the company to make its most difficult and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, we have identified the following critical accounting policies. Although we believe that our estimates and assumptions are reasonable, they are based upon information available when they are made. Actual results may differ significantly from these estimates under different assumptions or conditions.
Revenue recognition — We recognize revenue when it is realized or realizable and earned. In accordance with the Securities and Exchange Commission Staff Accounting Bulletin 104, Revenue Recognition, we consider revenue realized or realizable when persuasive evidence of an arrangement exists, the product has been shipped or the services have been provided to the customer, title and risk of loss of products has passed to the customer, the sales price is fixed or determinable, and collectibility is reasonably assured. Our terms are F.O.B. shipping point with no right of return, and customer acceptance of our products is not required. The revenue recognition policy does not differ among the various product lines, the marketing venues, or various geographic destinations. We do not have
16
Table of Contents
distributors who stock our equipment. We do not offer rebates, price protection, or other similar incentives, and discounts when offered are recorded as a reduction in revenue.
Revenue for preventive maintenance agreements is recognized on a per visit basis and extended warranties on a straight-line basis over the life of the contracts, in accordance with FASB Technical Bulletin 90-1, Accounting for Separately Priced Extended Warranty and Product Maintenance Contracts.
ASC Topic 605 provides revenue recognition guidance for arrangements with multiple deliverables, and the criteria to determine if items in a multiple deliverable agreement should be accounted for separately. If products or services are sold on a standalone basis, revenue is recognized as the products or services are delivered. When products or services are sold as part of a multiple element arrangement, we allocate revenue on a relative fair value basis.
Allowance for doubtful accounts and sales returns — Our allowance for doubtful accounts and sales returns is for accounts receivable balances that are estimated to be uncollectible as well as anticipated sales returns. The reserve is based on a number of factors, including: (1) an analysis of customer accounts and (2) our historical experience with accounts receivable write-offs and sales returns. The analysis includes the age of the receivable, the financial condition of a customer or industry and general economic conditions. We believe our financial results could be materially different if historical trends do not reflect actual results or if economic conditions worsened for our customers. In the event we determined that a smaller or larger allowance for doubtful accounts is appropriate, we would record a credit or charge to selling, general and administrative expense in the period that we made such a determination. As of September 30, 2009, we had $135,000 reserved against our accounts receivable for doubtful accounts and sales returns.
Accrual for excess and obsolete inventories — We perform an analysis to identify excess and obsolete inventory. We record a charge to cost of sales for amounts identified. Our analysis includes inventory levels, the nature of the finished product and its inherent risk of obsolescence and the on-hand quantities relative to the sales history of that finished product. We believe that our financial results could be materially different if historical trends do not reflect actual results or if demand for our products decreased because of economic or competitive conditions or otherwise. As of September 30, 2009, we had $312,000 accrued for excess and obsolete inventories.
Recoverability of long-lived assets — We assess the recoverability of goodwill and other long-lived assets annually or whenever events or changes in circumstances indicate that expected future undiscounted cash flows might not be sufficient to support the carrying amount of an asset. We deem an asset to be impaired if a forecast of undiscounted future operating cash flows is less than an asset’s carrying amount. If an asset is determined to be impaired, the loss is measured as the amount by which the carrying value of the asset exceeds its fair value. Changes in our business strategies, changes in the economic environment in which we operate, competitive conditions, and other factors could result in future impairment charges.
Accrued product warranties — Our products are generally covered by a warranty, with warranty periods ranging from ninety days to one year from the date of sale. Estimated warranty costs are accrued in the same period in which the related revenue is recognized, based on anticipated parts and labor costs, utilizing historical experience. Additional warranty reserves are also accrued for major rework campaigns. We periodically assess the adequacy of our warranty reserves based on changes in these factors and record any necessary adjustments if actual claim experience indicates that adjustments are necessary. Although we believe the likelihood to be relatively low, warranty claims experience could be materially different from actual results due to manufacturing changes that could impact product quality, a change in our warranty policy in response to industry trends, as yet unrecognized defects in products sold, or other factors. As of September 30, 2009, we had $211,000 accrued for future estimated warranty claims.
17
Table of Contents
Income taxes — In the preparation of our consolidated financial statements, management is required to estimate income taxes in each of the jurisdictions in which we operate. This process involves estimating actual current tax exposures together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included in our Consolidated Balance Sheets.
Management reviews the deferred tax assets for recoverability on a quarterly basis and assesses the need for valuation allowances. These deferred tax assets are evaluated by considering historical levels of income, estimates of future taxable income streams and the impact of tax planning strategies. A valuation allowance is recorded to reduce deferred tax assets when it is determined that it is more likely than not that we would not be able to realize all or part of our deferred tax assets. At September 30, 2009 and December 31, 2008, we provided a valuation allowance in the approximate amount of $370,000 and $364,000, respectively, against our net deferred tax assets, related primarily to the capital loss carryforward.
Forward-Looking Statements
This quarterly report on Form 10-Q contains or incorporates by reference not only historical information, but also forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created by those sections. In addition, we or others on our behalf may make forward-looking statements from time to time in oral presentations, including telephone conferences and/or web casts open to the public, in press releases or reports, on our website or otherwise. All statements other than statements of historical facts included in this report that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements about our plans, objectives, strategies and prospects regarding, among other things, our financial condition, results of operations, addressable market size estimates and business. We have identified some of these forward-looking statements with words like “believe,” “may,” “could,” “might,” “forecast,” “possible,” “potential,” “project,” “will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate,” “approximate” or “continue” and other words and terms of similar meaning. These forward-looking statements may be contained in the notes to our consolidated financial statements and elsewhere in this report, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Forward-looking statements involve risks and uncertainties. These uncertainties include factors that affect all businesses as well as matters specific to us. Some of the factors known to us that could cause our actual results to differ materially from what we have anticipated in our forward-looking statements are described below.
· Increases in prices for raw materials;
· Risks inherent in operating internationally and selling and shipping our products and purchasing our products and components internationally;
· Fluctuations in foreign currency exchange rates and interest rates;
· Failure to develop new products and technologies, delays in new product introduction and lack of market acceptance of new products;
· Failure to effect strategic acquisitions and integrate effectively newly acquired operations;
· Incurrence of additional debt, contingent liabilities and expenses in connection with future acquisitions;
· The effects of the global economic downturn and continuing decreases in capital spending by our customers that may occur as a result;
· Exposure to assertions of intellectual property claims and failure to protect our intellectual property;
· Disruption in our ability to manufacture our products or the ability of our key suppliers to
18
Table of Contents
provide us products or components or raw materials for products resulting in our inability to supply market demand for our products;
· Reliance on independent sales distributors and sales associates to market and sell our products;
· Highly competitive nature of the markets in which we sell our products and the introduction of competing products;
· Loss of customers;
· Failure to retain senior management or replace lost senior management;
· Employee slowdowns, strikes or similar actions;
· Reliance on our management information systems for inventory management, distribution, accounting and other functions;
· Effects of any pending or threatened litigation;
· Failure to comply with applicable laws and regulations and adverse changes in applicable laws or regulations;
· Changes in generally accepted accounting principles; or
· Conditions and changes in general economic and business conditions.
For more information regarding these and other uncertainties and factors that could cause our actual results to differ materially from what we have anticipated in our forward-looking statements or could otherwise materially adversely affect our business, financial condition or operating results, see our annual report on Form 10-K for the fiscal year ended December 31, 2008 under the heading “Part I — Item 1A. Risk Factors” on pages 8 through 12 of such report and the risk factor below.
We wish to caution readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described above and the risk factor set forth below, as well as others that we may consider immaterial or do not anticipate at this time. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. The expectations reflected in our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties, including those described above. The risks and uncertainties described above are not exclusive and further information concerning us and our business, including factors that potentially could materially affect our financial results or condition, may emerge from time to time. We assume no obligation to update forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. We advise you, however, to consult any further disclosures we make on related subjects in our quarterly reports on Form 10-Q and current reports on Form 8-K we file with or furnish to the Securities and Exchange Commission.
We have spent significant resources to develop new products in the food and beverage safety and packaging industries and we have thus far only realized minimal revenues from these products.
As more fully described elsewhere in this quarterly report, we have recently developed and begun to market our newest BevAlert system and OpTech-O2 Platinum analyzer. We believe that there are significant addressable markets for both of these products and while we believe both of these products are superior in many respects to other similar products being sold by our competitors, each one is new to the marketplace and may not gain the market acceptance necessary to allow us to capitalize on what we believe will be an increasing demand in the food and beverage industries for safety testing and monitoring products. We have realized modest revenues from sales of our BevAlert system and have just begun commercial production of our OpTech-O2 Platinum analyzer. If we are not able to successfully market these products, we will not recover the R&D and other expenses we have incurred to bring these products to market.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Equity Price and Interest Rate Risk
All of our marketable securities, the majority of which are insured by the FDIC, are at fixed interest rates and mature within two years; therefore, we believe that the market risk arising from the holding of these financial instruments is minimal.
Foreign Currency Risk
Historically, in excess of 50% of our consolidated sales have been to international destinations. Since we invoice most of these customers in U.S. dollars, we do not have significant exposure to foreign currency transaction risk. We invoice a small amount to our international customers in their local currency which exposes us to some transaction gain or loss when converting their payments into U.S.
19
Table of Contents
dollars. We also pay a small number of our international suppliers in their local currency which exposes us to transaction gain or loss. However, these have not resulted in material amounts in the past. Our foreign operations expose us to foreign currency exchange risk when the euro and yuan currency results of operations are translated to U.S. dollars. While we historically have not experienced any material foreign currency translation losses, we may engage in hedging activity in the future to minimize this risk. Our net investment in foreign subsidiary translated into U.S. dollars is not hedged. Any changes in foreign currency exchange rates would be reflected as a foreign currency translation adjustment, a component of accumulated other comprehensive income in stockholders’ equity, and would not impact our net income.
Item 4T. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered in this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of such period, to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that material information relating to our Company and our consolidated subsidiaries is made known to management, including our Chief Executive Officer and Chief Financial Officer, particularly during the period when our periodic reports are being prepared.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting that occurred during our quarter ended September 30, 2009 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1A. Risk Factors
We are affected by risks specific to us as well as factors that affect all businesses operating in a global market. The significant factors known to us that could materially adversely affect our business, financial condition or operating results are described in our annual report on Form 10-K for the fiscal year ended December 31, 2008 under the heading “Part I — Item 1A. Risk Factors.” There has been no material change in those risk factors.
20
Table of Contents
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
Unregistered Sales of Equity Securities
We did not sell any equity securities of MOCON, Inc. during the third quarter ended September 30, 2009 that were not registered under the Securities Act of 1933.
Issuer Repurchases of Equity Securities
The following table shows our stock repurchase activity during the third quarter ended September 30, 2009:
Period | | Total Number of Shares Purchased | | Average Price Paid Per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Maximum Amount of Authorization Remaining Under the Plan | |
July 1, 2009 through July 31, 2009 | | — | | — | | — | | $ | 2,000,000 | |
August 1, 2009 through August 31, 2009 | | 242,400 | (1) | $ | 8.25 | | 242,400 | | — | |
September 1, 2009 through September 30, 2009 | | — | | — | | — | | — | |
| | | | | | | | | | | |
(1) The 242,400 shares repurchased during the periods indicated above exhausted the amount remaining in the June 23, 2009 authorization by our Board of Directors. We currently are not authorized by our Board of Directors to make further repurchases of our common stock.
Except as set forth in the table above, we did not purchase any shares of our common stock or other equity securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, during the third quarter ended September 30, 2009.
21
Table of Contents
Item 6. Exhibits
The following exhibits are being filed or furnished with this quarterly report on Form 10-Q:
Exhibit No. | | Description |
31.1 | | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
31.2 | | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| | |
32.1 | | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| | |
32.2 | | Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
22
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MOCON, INC. |
| |
| |
Date: November 13, 2009 | /s/ Robert L. Demorest |
| Robert L. Demorest |
| Chairman, President and Chief Executive Officer |
| (Principal Executive Officer) |
| |
| |
Date: November 13, 2009 | /s/ Darrell B. Lee |
| Darrell B. Lee |
| Vice President, Treasurer and Chief Financial Officer |
| (Principal Financial and Accounting Officer) |
23
Table of Contents
MOCON, INC.
QUARTERLY REPORT ON FORM 10-Q
QUARTER ENDED SEPTEMBER 30, 2009
EXHIBIT INDEX
Exhibit No. | | Description | | Method of Filing |
31.1 | | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | Filed herewith |
| | | | |
31.2 | | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | | Filed herewith |
| | | | |
32.1 | | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | Furnished herewith |
| | | | |
32.2 | | Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | | Furnished herewith |
24